• Study on the Effectiveness and Safety of Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Denmark Ireland
  • Study on ECUR-506A and ECUR-506D for Male Infants Under 9 Months with Neonatal Onset Ornithine Transcarbamylase Deficiency

    Not recruiting

    2 1 1
    Spain
  • Study Comparing Ribociclib and Palbociclib for Patients with Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer

    Not recruiting

    3 1 1 1
    Portugal Spain
  • Study of RLY-4008 for Patients with Cholangiocarcinoma and Other Advanced Solid Tumors

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Germany The Netherlands Spain Sweden
  • Study on Botulinum Toxin Type A and Capsaicin for Treating Postmastectomy Pain in Women After Breast Cancer Surgery

    Not recruiting

    3 1 1 1
    Spain
  • Study Comparing Trastuzumab Deruxtecan with Chemotherapy for Patients with HER2-Low, Hormone Receptor Positive Breast Cancer After Endocrine Therapy Progression

    Not recruiting

    3 1 1 1
    Austria Belgium Denmark France Germany Hungary +6
  • Study of Acalabrutinib and Rituximab for Elderly Patients with Untreated Mantle Cell Lymphoma

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark Finland Norway Sweden
  • Study on the Safety of TAK-755, Rituximab, and Glucocorticoids for Patients with Immune-Mediated Thrombotic Thrombocytopenic Purpura (iTTP)

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    Austria Greece Italy Poland Spain
  • Study of Emavusertib for Patients with Acute Myelogenous Leukemia or Myelodysplastic Syndrome

    Not recruiting

    1 1 1
    Investigated Drugs:
    France Germany Spain
  • Study on the Effects of Dapagliflozin on Blood Vessel Health in Patients with Chronic Kidney Disease

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    France

powered by